A ‘world of knowledge’ to help Australian doctors better diagnose inherited diseases
UMCCR investigator, Associate Professor Oliver Hofmann, is part of a new global 'learning health system' that will enable researchers to share genome sequencing data to investigate and diagnose genetic disorders, and ultimately pave the way for equitable delivery of genomic medicine.News
Specialist Cancer Nurses: Why they matter
Although technology may have changed the role of nurses, what they do for cancer care is more important than ever. By Professor Meinir Krishnasamy, inaugural Chair in Cancer Nursing at the University of Melbourne.News
The Li Ka Shing Foundation will donate US$3 million (A$3.75 million) to a team of University of Melbourne researchers, working to turn cancer into a manageable chronic disease.News
University of Melbourne researchers are leading a new effort to use genomics and personalised medicine against some of the most lethal cancersNews
Scientists uncover the genetic script that drives pancreatic tumours, opening the door on new personalised treatments for a deadly disease.News
Professor Sean Grimmond is bringing groundbreaking genome-directed cancer research into the clinical space to change the way we treat cancer.News
By Jon Emery : Professor of Primary Care Cancer Research, University of MelbourneNews
Led by Professor Sean Grimmond, the University of Melbourne Centre for Cancer Research (UMCCR) aims to foster innovation and integration in cancer care, research, education and training to achieve a world-leading cancer centre and workforce. It brings together leading cancer researchers from across the University to enable collaboration that ultimately results in improved outcomes for cancer patients.
The UMCCR focuses on improving the molecular detection and diagnosis of cancer, improving therapeutic decisions for patients through computational oncology, and enabling innovative programs in personalised cancer care.
Based at the Victorian Comprehensive Cancer Centre (VCCC), the UMCCR facilitates the sharing of infrastructure and supports collaboration within the Melbourne Biomedical Precinct and the wider VCCC alliance.
The UMCCR works in a wide variety of cancers including breast, ovarian, prostate, colorectal, pancreatic, neuroendocrine, gastric, oesophageal and melanoma, but recalcitrant cancers – for which the standard of care has changed little over the last 30 years – is an emerging theme.